SEC Form D · Amendment · filed November 9, 2023
Voltron Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
James Ahern · New York, NYDirectorAnthony Zook · New York, NYDirectorMatthew Eitner · New York, NYDirectorPatrick Gallagher · New York, NYExec · DirectorMatthew Duffy · New York, NYExec · DirectorPaul Korner · New York, NYDirectorIlfryn Carstairs · Minneapolis, MNExec · DirectorAneek Mamik · Minneapolis, MNDirectorTimothy Mooney · Minneapolis, MNDirectorMarcia Page · Minneapolis, MNDirectorHaseeb Malik · Minneapolis, MNExec · DirectorBradley Bauer · Minneapolis, MNDirectorGeorge M. Ager, Jr · Southampton, PADirectorRobert T. Strong · Southampton, PADirectorJames J. Clarke · Southampton, PAExec · DirectorJohn J. Augustine · Southampton, PADirectorAndrew E. Dipiero, Jr · Southampton, PADirectorKenneth R. Gant · Southampton, PAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗